All stock lists
908 Devices Inc. (NASDAQ:MASS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Specialties
11.74+0.26 (+2.22%)
Market cap
$485M
Health Score
Analyst consensus
Listed since
Dec 18, 2020
Website
Insider Score
––Not scored
MASS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
MASS analyst forecast
MASS analyst consensus
Moderate Buy2 ratings
Buy 2 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
MASS 12-month price target
No published price targets in the last 12 months.
Best analysts covering MASS
- Stifel100%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
MASS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Stifel | Buy | — | — | Reiterated | 2026-08-12 |
| — | Roth Capital | Buy | — | — | Reiterated | 2026-08-12 |
| — | Leerink Partners | Outperform | — | — | Upgraded | 2025-08-05 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2025-01-15 |
| — | Leerink Partners | Market Perform | — | — | Downgraded | 2024-11-13 |
| — | Stifel | Buy | — | — | Reiterated | 2024-11-13 |
| — | Leerink Partners | Outperform | — | — | Reiterated | 2024-10-17 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-05-13 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-09-25 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2023-02-07 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2023-01-06 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-11-15 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2022-03-08 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-05-14 |
| — | Stifel | Buy | — | — | Reiterated | 2021-01-12 |
| — | Cowen & Co. | Outperform | — | — | Reiterated | 2021-01-12 |
| — | SVB Leerink | Outperform | — | — | Reiterated | 2021-01-12 |
MASS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-03 | -0.06 | -0.05 | $15.8M | $17.4M |
| 2026-05-06 | -0.15 | -0.22 | $13.2M | $13.4M |
| 2026-08-11 | -0.14 | -0.32 | $15.4M | $16.1M |
| 2026-11-09 | -0.16 | 0.00 | $18.3M | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.